Reply to: Opioids for dyspnoea in interstitial lung disease: does the sequence and timing of therapy matter?

Ferreira, Diana H; Ekström, Magnus; Bajwah, Sabrina; Janssen, Daisy J A; Fazekas, Belinda; Currow, David C

Ferreira, Diana H; Ekström, Magnus; Bajwah, Sabrina; Janssen, Daisy J A; Fazekas, Belinda; Currow, David C.

Affiliation

Ferreira DH; Graduate School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia diana.mbhf@gmail.com.
Ekström M; Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden.
Bajwah S; Cicely Saunders Institute, King's College London, London, UK.
Janssen DJA; Department of Health Services Research and department of Family Medicine, Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Fazekas B; Department of Research and Development, Ciro, Horn, The Netherlands.
Currow DC; Faculty of Health, University of Technology Sydney, Ultimo, Australia.

Eur Respir J ; 64(1)2024 Jul.

Article de En | MEDLINE | ID: mdl-38991720

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pneumopathies interstitielles / Dyspnée / Analgésiques morphiniques Limites: Humans Langue: En Journal: Eur Respir J Année: 2024 Type de document: Article Pays d'affiliation: Australie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google